Background. Failed kidney transplant is becoming a frequent cause of dialysis initiation. Although studies have shown no difference between peritoneal dialysis (PD) and haemodialysis (HD) in terms of patients and technique survival, PD remains quite rarely used in this condition. Studies in larger multicentre matched cohorts are missing. Methods. We conducted a retrospective study about 328 patients registered in the French Language Peritoneal Dialysis Registry (RDPLF) who started PD after kidney transplant failure (Tx group) between January 2002 and December 2012 who were compared with 656 matched never-transplanted patients having started PD during the same period (control group). Patients and PD technique survival as well as peritonitis episodes were analysed. Results. Over the study period, patients' survival was similar between the two groups (P ¼ 0.34). The mean time on PD was significantly shorter for patients in the Tx group [17 months (range 14-20)] compared with the control group [21 months (range 19-23)] (P ¼ 0.003). The main cause of transfer to HD was for both group adequacy and/or ultrafiltration failure. Peritonitis rates were similar in the two groups: 43.6% (n ¼ 143) versus 40.1% (n ¼ 263) in the Tx and control group, respectively (P ¼ 0.3). In multivariate Cox analysis, kidney transplant failure (P < 0.0001), younger age (P ¼ 0.02) and male gender (P ¼ 0.01) were associated with a higher risk of transfer to HD. Using multivariate competing risk analysis, kidney transplant failure was again observed as a predictive factor (P < 0.0001), but not age and gender. The only other significant predictive factor observed was peritonitis episodes experienced during PD treatment (P ¼ 0.002). Conclusions. Comparing the Tx and control groups, we report similar patient survival and peritonitis rates but a higher PD technique failure in the Tx group.
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I N T R O D U C T I O N
Nephrologists have to deal with an increasing number of patients returning to dialysis after kidney transplant failure. According to the annual report of the Biomedicine Agency published in 2013, this number accounts for 10% entering dialysis and represents 186 patients in the 21 French study centres. Among these patients, 86.7% returned to haemodialysis (HD) and only 5.1% to peritoneal dialysis (PD). This raises the question of whether the choice of dialysis modality has an impact on patient outcome following failed kidney transplantation. There are conflicting data in the literature and only a few publications on the subject. Two different studies showed that patients starting PD after kidney transplant failure had a similar outcome to those treated by HD [1, 2] . Three different studies have shown that failed kidney transplantation does not adversely affect patient outcome on PD [3] [4] [5] . Only a single-centre retrospective study found that these patients had a worse outcome on PD compared with non-transplanted patients [6] . It is worth noting that most of the studies published included a limited number of patients (<100). In most cases, the two different populations (with or without kidney transplantation prior PD) were not matched, despite the fact that patients starting PD after failed kidney transplantation were younger and had less diabetes mellitus and fewer comorbidities.
As such, there is no evidence that one dialysis method leads to a better outcome after kidney transplantation failure. PD remains an option for these patients who are usually young, have typically enjoyed relative independence and for whom PD may well be attractive.
The aim of this study is to compare, in a large incident cohort of PD patients from the French Language Peritoneal Dialysis Registry (RDPLF), the outcomes of patients with and without failed kidney transplantation prior to the start of PD.
M A T E R I A L S A N D M E T H O D S

Study population
The RDPLF was set up in 1986. In France, 82% of all PD patients are registered in the RDPLF. Participating centres provide updated information regarding their patients every 3 months. We conducted a retrospective multicentre study using data from the RDPLF and including all French incident PD patients (>18 years of age) starting PD between 1 January 2002 and 31 December 2012. During this period, 12 446 patients started PD and among them 328 patients (2.6%) started after a first kidney transplant failure (Tx group).
They were matched with 656 age-and sex-matched nevertransplanted patients who started PD during the same period (control group). The end of the observation period was 31 December 2014. Therefore two groups are considered in this study: patients starting PD after kidney transplant failure (Tx group) and a control group including patients never transplanted.
Demographic and clinical characteristics at inclusion
Covariates extracted from the registry were age, gender, diabetes mellitus, PD modality 3 months after dialysis start [automated PD (APD) or continuous ambulatory PD (CAPD), assisted PD or not). To assess patient comorbidities we extracted the Charlson Comorbidity Index (CCI) from the database. The causes of transfer to HD and number of peritonitis episodes were also collected.
Follow-up, outcomes
Patients still on PD were followed until December 2014. For the others, the end of follow-up was determined according to death, transfer to HD, kidney transplantation, recovery of renal function or transfer out/unknown.
Statistical analysis
Continuous variables were described by the median value and categorical variables as proportions. The univariate analysis was performed with v 2 for categorical variables and MannWhitney test for continuous variables.
For the outcome measurements, an individual was censored at death or at the end of the PD period (kidney transplantation, transfer to HD, etc.). Univariate Cox analysis was used to select parameters influencing transfer to HD in the total cohort. Only variables with a P-value 0.10 were selected. The selected variables were included into a Cox proportional hazards model and a backward stepwise selection process was performed, this time at a classical a ¼ 0.05.
However, the Kaplan-Meier method is known to overestimate the probabilities of events of interest when there are competing events. Here, death and renal transplantation as competing events of transfer to HD provide justification for competing risk analysis (Fine and Gray model).
Kaplan-Meier and cumulative incidence function curves of survival free of transfer to HD for the two groups were drawn.
Using continuous variables in the Cox model, the restricted cubic splines method with graphical evaluation was used to exclude a potential non-linear relationship between predictors (such as age, CCI and the number of peritonitis episodes) and the event of interest, here, the HD transfer (Supplementary data).
The assumption of proportionality of the hazard ratio (HR) to be transferred to HD was checked by plotting log-minus-log survival curves (Supplementary data).
Sensitivity analyses were used to explore the robustness of the final multivariate Cox and Fine and Gray models with first a stratified approach on the type of centre and then with the use of a robust sandwich covariance matrix estimate to account for the intracluster dependence based on the type of centre (Supplementary data).
R E S U L T S
Baseline patient characteristics Table 1 presents the characteristics of the two groups. The median age at PD initiation was 50 years. The CCI was similar in the two groups (median CCI ¼ 4 in both groups). However, 
Follow-up
The mean time on PD was significantly shorter for patients from the Tx group: 17 months (range 14-20) compared with 21 months (range 19-23) in the control group (P ¼ 0.004).
At the end of the study, 43 (13%) and 81 patients (12.4%) were still on PD in the Tx and control groups, respectively (P ¼ 0.8).
Over the study period, 82 (12.5%) and 33 (10.1%) patients died in the control and Tx groups, respectively (P ¼ 0.3).
Patients in the Tx group were significantly more frequently transferred to HD (44.2% versus 30.2% in the control group; P < 0.0001). As expected, they also had less access to a new transplantation (29.2% versus 39.6% in the control group; P ¼ 0.002) ( Table 2) .
Peritonitis
There was no difference in peritonitis rates between the two groups. A total of 143 patients (43.6%) from the Tx group experienced at least one episode of peritonitis compared with 263 patients (40.1%) in the control group (P ¼ 0.3) ( Table 2 ). First peritonitis episodes did not occur earlier in the Tx group compared with the control group [7.2 months (range 0-105) versus 9.1 (0-71), respectively; P ¼ 0.06]. Moreover, PD technique failure due to an episode of peritonitis was not different between the two groups [33 patients (16.7%) and 24 patients (16.8%) in the control and Tx groups, respectively (P ¼ 0.9)] (Table 5) .
PD technique survival
Patients in the Tx group experienced a higher technique failure rate.
Using Cox models, the 2-year survival free of transfer to HD was 59% in the Tx group and 77.7% in the control group (P < 0.0001) (Figure 1) . In univariate analysis, younger age (P ¼ 0.0003), male gender (P ¼ 0.006), lower CCI (P ¼ 0.05), non-assisted PD (P ¼ 0.002) and kidney transplant failure prior PD start (P < 0.0001) were associated with an increased risk of PD technique failure. (Table 3) .
Using competing risk analysis, in univariate analysis, except for younger age and lower CCI we found the same predictive factors plus experiencing at least one peritonitis episode during PD treatment (P ¼ 0.003). In multivariate analysis, again kidney transplant failure prior to PD was associated with PD technique failure [HR 1.68 (95% CI 1.35-2.08), P < 0.0001]. The only other significant predictive factor was peritonitis episode experienced during PD treatment [HR 1.38 (95% CI 1.12-1.71), P ¼ 0.002] ( Table 4 ). Figure 2 presents the cumulative incidence function curve issued from Fine and Gray analysis.
Sensitivity analyses provide similar results and the parameter of past history of kidney transplantation remains strongly associated with the transfer to HD (Supplementary data). Peritoneal dialysis after kidney transplantation
Considering causes of transfer to HD, no difference was observed between the two groups (Table 5) .
D I S C U S S I O N
Allograft failure is now a frequent cause of end-stage renal disease (ESRD) and represents a significant part of patients starting dialysis. However, PD in this situation remains rarely used (here, 2.6% of PD patients over a 10-year period). We report from a large French national cohort that patients with a failed transplant as the cause of ESRD have significantly lower PD technique survival rates. Nevertheless, patient survival and the risk of peritonitis were not different.
The association between PD technique failure and failed transplantation before PD start does not mean causality and the interpretation of outcomes of patients starting dialysis after kidney transplant failure is obviously critically dependent on the choice of the control group. Previous studies used either no control group or a control group defined as either 'all patients initiating PD or any form of dialysis at the same centre' or 'patients at the same centre matched for age and diabetes'. Methodologically, the inclusion of patients in the same centre may reflect practice rather than a true effect. A nationwide cohort as used in this study reduces this bias. It should also be noted that patients with a failed transplant may differ from other patients. Two large-scale studies showed that patients starting PD after allograft failure were younger and presented with fewer comorbidities and less diabetes mellitus than the non-transplanted patients [3, 4] . In our study, we matched patients on age as well as gender and PD period. Considering comorbidities, patients in the two groups had similar CCIs. Diabetes mellitus was more frequent in patients without a failed kidney transplant. Notwithstanding the known negative impact of diabetes mellitus on PD technique survival, we still observed a better PD technique survival in the control group. As expected, our control group had easier access to transplantation than the Tx group already transplanted once before. We cannot rule out that the difference observed in terms of PD duration between the two groups would have likely been more important if we were considering two groups matched on access to transplantation. We observed a significantly higher rate of PD technique failure in patients with ESRD due to transplant failure. In the literature, only a single study by Sasal et al. [6] reported increased higher mortality and technique failure in these patients. Indeed, Davies [1] prospectively compared the clinical outcomes of 45 patients returning to dialysis (28 returning to PD and 17 returning to HD) with failed kidney transplantation to those of 469 patients new on dialysis between 1989 and 2001. The failed transplant group was significantly younger than the never-transplanted patients. However, after adjustment for age and comorbidity, no difference in either patient survival or PD technique failure was seen between the two groups. Note that this study extends over a wide period with practices that may have changed during the study [1] . In our study including patients over a 10-year period, PD periods (the first 5 years versus the last 5 years) did not influence PD technique survival.
Our result also appears to contradict results from Mujais and Story [3] , who compared three groups matched for age, gender, diabetes, PD modality, centre activity and cohort year (494 failed transplant patients, 491 new patients to PD and 479 patients transferred from HD). They did not observe any significant difference regarding technique survival. In multivariate analysis, centre activity was the major predictor of technique success in all three groups. Unfortunately our patients were not matched for centre size. It is worth noting that unlike us, none of the studies published to date used a competing risk model to analyse PD technique survival, only a Cox model censured at death, transplantation and/or lost to follow-up, which could lead to biased survival curves.
In our study, the main cause of transfer to HD was adequacy and/or ultrafiltration failure. A more rapid decline of residual renal function (RRF) in patients with failed kidney transplant could explain a higher frequency of dialysis inadequacy. Three previous studies have shown that the decline of residual RRF was more rapid in failed kidney transplant patients starting PD compared with patients never transplanted [1, 7, 8] . In contrast, Bernardo et al. [9] did not show any difference in the decline of RRF between 22 patients starting PD after renal transplant failure and 126 patients new on PD with native kidney, with only diabetes status reported as a determinant of RRF decline. Unfortunately, no data about RRF over the time of the study were available in our cohort. In our study, we also assume that some French nephrologists think that patients must be systematically transferred to HD after the occurrence of anuria, possibly more frequent in Tx group, even if the European Automated Peritoneal Dialysis Outcomes Study clearly showed that PD was a suitable method for anuric patients [10] . Another explanation for more transfers to HD due to adequacy/ultrafiltration failure in the Tx group could be linked to a chronic systemic and peritoneal inflammatory state that has also been noted in patients returning to HD after a failed kidney transplant [11] . Chronic systemic inflammation may play a role in the loss of RRF and chronic peritoneal inflammation in the development of a high transport state, which both could explain a higher PD technique failure. Wilmer et al. [12] reported a 2 times greater likelihood of developing a peritoneal equilibration test (PET) score in the high transport range in 19 patients with failed kidney transplant and on PD since 1 month. Patients in the high peritoneal transport range were also more often Peritoneal dialysis after kidney transplantation transferred to HD. It should be noted in this small size group that no demographic or transplant-related parameters differed between the high peritoneal transport group and the group of 'other' transport states [12] . In our study, patients with failed kidney transplant were more frequently on APD than those of the control group. With the two groups being matched for age and having the same level of comorbidity, it is difficult to interpret this difference as reflecting less autonomy in the control group. Alternatively, predisposition to a higher peritoneal transport state in failed kidney transplant starting PD may explain this difference. Unfortunately, no peritoneal transport status was available in the RDPLF database to verify this hypothesis. Moreover, the degree of systemic and para-abdominal inflammation experienced by these patients with failed kidney transplant as well as continuation/withdrawal of immunosuppression and transplantectomy need further investigations to assess their impact on PD technique survival. Because of the practice of immunosuppression continuation after kidney allograft failure, sometimes for long periods, concern has been raised about a higher rate of peritonitis. Failed transplant before PD start was not associated with a higher risk of peritonitis in our study. The preponderance of published data suggests that peritonitis rates are not different between patients on PD after failed kidney transplant and other PD patients [4] [5] [6] . However, Han et al. [13] showed that high-dose and chronic exposure to steroids was associated with a high risk of peritonitis in 41 transplanted patients (20 with low-dose and 21 with high-dose steroids) between 2010 and 2015. Peritonitis is harmful to the peritoneum and can accelerate structural changes in the peritoneal membrane, leading to peritoneal fibrosis. The intensity of peritoneal inflammation and the frequency of infection have an impact on peritoneal function. Peritonitis episodes could cause membrane permeability changes and ultrafiltration declines with time on PD, which finally leads to technique failure. Peritonitis is widely recognized in the literature as affecting PD patients' 'technique survival and mortality' [14] [15] [16] . In our study, it is only by using a competing risk model that we found previous history of a peritonitis episode as a predictive factor of transfer to HD. Unfortunately, because of a lot of missing data, microbiologic characteristics of peritonitis episodes in this study could not be investigated.
Our study has some limitations. Because dialysis period before transplantation, immunosuppressive therapy management, need for transplantectomy and monitoring of clinical and adequacy parameters (ultrafiltration rate, RRF, weekly Kt/V urea and PET results) were not collected in the registry, we could not study their impact on PD technique failure.
In conclusion, our study indicates in a large cohort that PD is a suitable method for failed kidney transplant patients. Whereas patient survival and peritonitis rate were similar, we observed higher technique PD failure among patients with ESRD due to transplant failure and also influenced by peritonitis experienced during PD therapy. These results need further investigation to explain the mechanisms. Indeed, a better characterisation of patients starting PD after kidney transplant failure could help nephrologists in the selection and medical care of these patients.
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